| Mobile Web

Retatrutide shows knee osteoarthritis pain relief in trials

Eli Lilly’s next-generation obesity treatment retatrutide showed effectiveness in weight loss and easing knee osteoarthritis pain in large clinical trials. In two phase 3 studies published in The New England Journal of Medicine, weekly injections produced greater weight reduction and improved pain scores than placebo in overweight or obese adults without type 2 diabetes who also had knee osteoarthritis. Serious adverse events were more frequent than with placebo, with common side effects including nausea and diarrhoea.